Rare diseases
Investigational molecules
Locations
Back to France229 clinical trials in Suresnes, France across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Safety and Tolerability of Benralizumab in Patients with HES, EGPA, or Asthma Who Completed a Prior Study
FranceA Phase 3 Randomized Study of mRNA‑4157 plus Pembrolizumab as Adjuvant Therapy in Patients with Completely Resected Stage I Non‑Small Cell Lung Cancer
FrancePhase 3 study of ZL-1310 versus topotecan hydrochloride in patients with relapsed small cell lung cancer
FrancePhase III Randomized Study of Rilvegostomig vs. Pembrolizumab with Platinum-based Chemotherapy in PD-L1 Expressing Metastatic Squamous NSCLC
FranceA Study of Brenipatide Compared to Placebo for Adults with Uncontrolled Moderate to Severe Asthma
FranceA Study of Ivonescimab Combined with Fluorouracil, Folinic Acid, and Oxaliplatin Compared to Bevacizumab for Patients with Metastatic Colorectal Cancer
FranceStudy on the Safety and Effectiveness of BNT327 with Chemotherapy for Patients with Non-Small Cell Lung Cancer
FranceStudy comparing rilvegostomig plus chemotherapy versus pembrolizumab plus chemotherapy for first-line treatment in patients with metastatic non-squamous lung cancer with PD-L1 expression
FranceStudy on Long-term Safety of Nivolumab and Drug Combination for Cancer Patients from Previous BMS Trials
FranceStudy on the Long-term Safety and Efficacy of Pembrolizumab and Lenvatinib for Patients with Advanced Tumors
FranceStudy of LY3537982, pembrolizumab, and a drug combination for patients with advanced non-small cell lung cancer and a KRAS G12C mutation
FranceAdjuvant Therapy with RO7435846 (divarasib) versus Pembrolizumab or Nivolumab or Observation in Patients After Surgery for Stage II‑III KRAS G12C NSCLC
FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on multiple cancer types, including lung, bladder, gastric, and colorectal cancers. Research evaluates new combination therapies and treatment approaches.
Studies explore novel drug combinations and immunotherapy approaches to improve patient outcomes.
Clinical investigations in neurological conditions, with particular focus on multiple sclerosis and cerebrovascular disorders.
Trials evaluate both established and experimental treatments to enhance patient care outcomes.
Research focusing on cardiac conditions, particularly examining innovative treatments for various forms of myocarditis.
Studies aim to improve therapeutic approaches and patient outcomes in cardiac conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
